|
|
DSpace at RU >
Search Results
Results 1-38 of 38.
Item hits:
| Full Text | Issue Date | Title | Author(s) | | 2011 | Cancer immunotherapy--revisited | Lesterhuis, W.J.; Haanen, J.B.; Punt, C.J.A. |
| 2011 | Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice | Lesterhuis, W.J.; Punt, C.J.A.; Hato, S.V.; Eleveld-Trancikova, D.; Jansen, B.J.H.; Nierkens, S.; Schreibelt, G.; Boer, A. de; Herpen, C.M. van; Kaanders, J.H.A.M.; Krieken, J.H. van; Adema, G.J.; Figdor, C.G.; Vries, I.J.M. de |
| 2011 | Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging | Aarntzen, E.H.J.G.; Srinivas, M.; Wilt, J.H. de; Jacobs, J.F.M.; Lesterhuis, W.J.; Windhorst, A.D.; Troost, E.G.C.; Bonenkamp, J.J.; Rossum, M.M. van; Blokx, W.A.M.; Mus, R.D.M.; Boerman, O.C.; Punt, C.J.A.; Figdor, C.G.; Oyen, W.J.G.; Vries, I.J.M. de |
| 2011 | Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used | Lesterhuis, W.J.; Schreibelt, G.; Scharenborg, N.M.; Brouwer, H.M.; Gerritsen, M.J.P.; Croockewit, S.; Coulie, P.G.; Torensma, R.; Adema, G.J.; Figdor, C.G.; Vries, I.J.M. de; Punt, C.J.A. |
| 2011 | Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients | Lesterhuis, W.J.; Vries, I.J.M. de; Schreibelt, G.; Lambeck, A.J.A.; Aarntzen, E.H.J.G.; Jacobs, J.F.M.; Scharenborg, N.M.; Rakt, M.W.M.M. van de; Boer, A.J. de; Croockewit, S.; Rossum, M.M. van; Mus, R.D.M.; Oyen, W.J.G.; Boerman, O.C.; Lucas, S.; Adema, G.J.; Punt, C.J.A.; Figdor, Carl |
| 2010 | Dendritic cells in cancer immunotherapy. | Lesterhuis, W.J. |
| 2010 | Immunogenicity of Dendritic Cells Pulsed with CEA Peptide or Transfected with CEA mRNA for Vaccination of Colorectal Cancer Patients. | Lesterhuis, W.J.; Vries, I.J.M. de; Schreibelt, G.; Schuurhuis, D.H.; Aarntzen, E.H.J.G.; Boer, A. de; Scharenborg, N.M.; Rakt, M.W.M.M. van de; Hesselink, E.J.; Figdor, C.G.; Adema, G.J.; Punt, C.J.A. |
| 2010 | A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. | Lesterhuis, W.J.; Vries, I.J.M. de; Aarntzen, E.H.J.G.; Boer, A. de; Scharenborg, N.M.; Rakt, M.W.M.M. van de; Spronsen, D.J. van; Preijers, F.W.M.B.; Figdor, C.G.; Adema, G.J.; Punt, C.J.A. |
| 2010 | Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients. | Jacobs, J.F.M.; Punt, C.J.A.; Lesterhuis, W.J.; Sutmuller, R.P.M.; Brouwer, H.M.; Scharenborg, N.M.; Klasen, I.S.; Hilbrands, L.B.; Figdor, C.G.; Vries, I.J.M. de; Adema, G.J. |
| 2009 | Isolated acral dermatitis due to graft-versus-host disease. | Velden, W.J.F.M. van der; Lesterhuis, W.J.; Blokx, W.A.M.; Schattenberg, A.V.M.B. |
| 2009 | Vascular endothelial growth factor in systemic capillary leak syndrome. | Lesterhuis, W.J.; Rennings, A.J.M.; Leenders, W.P.J.; Nooteboom, A.; Punt, C.J.A.; Sweep, C.G.J.; Pickkers, P.; Geurts-Moespot, A.; Laarhoven, H.W.M. van; Vlag, J. van der; Berden, J.H.M.; Postma, C.T.; Meer, J.W.M. van der |
| 2009 | Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells. | Schuurhuis, D.H.; Lesterhuis, W.J.; Kramer, M.; Looman, M.W.G.; Hout-Kuijer, M.A. van; Schreibelt, G.; Boullart, I.; Aarntzen, E.H.J.G.; Benitez-Ribas, D.; Figdor, C.G.; Punt, C.J.A.; Vries, I.J.M. de; Adema, G.J. |
| 2009 | Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. | Verdijk, P.; Aarntzen, E.H.J.G.; Lesterhuis, W.J.; Boullart, A.C.I.; Kok, E.; Rossum, M.M. van; Strijk, S.P.; Eijckeler, F.D.J.; Bonenkamp, J.J.; Jacobs, J.F.M.; Blokx, W.A.M.; Krieken, J.H.J.M. van; Joosten, I.; Boerman, O.C.; Oyen, W.J.G.; Adema, G.J.; Punt, C.J.A.; Figdor, C.G.; Vries, I.J.M. de |
| 2008 | Dendritic cell vaccines in melanoma: from promise to proof? | Lesterhuis, W.J.; Aarntzen, E.H.J.G.; Vries, I.J.M. de; Schuurhuis, D.H.; Figdor, C.G.; Adema, G.J.; Punt, C.J.A. |
| 2007 | Colitis in an alcohol-dependent woman. | Oude Lashof, A.M.L.; Lesterhuis, W.J.; Wanten, G.J.A.; Beckers, P.J.A.; Keuter, M. |
| 2007 | Het volgen van therapeutische cellen met magnetische resonantie. | Vries, I.J.M. de; Lesterhuis, W.J.; Barentsz, J.O.; Krieken, J.H.J.M. van; Raymakers, R.A.P.; Oyen, W.J.G.; Adema, G.J.; Heerschap, A.; Hoogerbrugge, P.M.; Punt, C.J.A.; Figdor, C.G. |
| 2007 | CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma. | Blokx, W.A.M.; Lesterhuis, W.J.; Andriessen, M.P.M.; Verdijk, M.A.J.; Punt, C.J.A.; Ligtenberg, M.J.L. |
| 2007 | Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. | Verdijk, P.; Scheenen, T.W.J.; Lesterhuis, W.J.; Gambarota, G.; Veltien, A.A.; Walczak, P.; Scharenborg, N.M.; Bulte, J.W.; Punt, C.J.A.; Heerschap, A.; Figdor, C.G.; Vries, I.J.M. de |
| 2007 | In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. | Vries, I.J.M. de; Bernsen, M.R.; Geloof, W. van; Scharenborg, N.M.; Lesterhuis, W.J.; Rombout, P.D.M.; Muijen, G.N.P. van; Figdor, C.G.; Punt, C.J.A.; Ruiter, D.J.; Adema, G.J. |
| 2006 | Vaccination of colorectal cancer patients with CEA-loaded dendritic cells : antigen-specific T cell responses in DTH skin tests | Lesterhuis, W.J.; Vries, I.J.M. de; Boullart, A.C.I.; Figdor, C.G.; Ruers, T.J.M.; Adema, G.J.; Punt, C.J.A. |
| 2006 | CMR 2005: 9.07: In vivo MR tracking of magnetically labeled dendritic cells: first clinical experience. | Barentsz, J.O.; Verdijk, P.; Vries, I.J.M. de; Lesterhuis, W.J.; Scheenen, T.W.J.; Boerman, O.C.; Oyen, W.J.G.; Adema, G.J.; Krieken, J.H.J.M. van; Bulte, J.; Punt, C.J.A.; Heerschap, A.; Figdor, C.G. |
| 2006 | Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests | Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Boullart, A.C.I.; Jacobs, J.F.M.; Boer, A.J. de; Scharenborg, N.M.; Brouwer, H.M.H.; Rakt, M.W.M.M.; Figdor, C.G.; Ruers, T.J.M.; Adema, G.J.; Punt, C.J.A. |
| 2006 | Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests. | Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Boullart, A.C.I.; Jacobs, J.F.M.; Boer, A.J. de; Scharenborg, N.M.; Brouwer, H.; Rakt, M.W.M.M. van de; Figdor, C.G.; Ruers, T.J.M.; Adema, G.J.; Punt, C.J.A. |
| 2005 | Acute arterial occlusion after chemotherapy for testicular cancer. | Lesterhuis, W.J.; Spronsen, D.J. van; Schultze Kool, L.J.; Mulder, P.H.M. de |
| 2005 | Vaccine-specific T cell responses in delayed-type hypersensitivity biopsies after dendritic cell vaccination correlate with clinical outcome | Boullart, A.C.I.; Vries, I.J.M. de; Bernsen, M.R.; Lesterhuis, W.J.; Scharenborg, N.M.; Figdor, C.G.; Adema, G.J.; Punt, C.J.A. |
| 2005 | Vaccination of colorectal cancer patients with carcincembryonic antigen peptide-loaded dendritic cells | Lesterhuis, W.J.; Vries, I.J.M. de; Schuurhuis, D.H.; Scharenborg, N.M.; Brouwer, M.; Boer, A.J. de; Figdor, C.G.; Ruers, T.J.M.; Adema, G.J.; Punt, C.J.A. |
| 2005 | Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy | Vries, I.J.M. de; Lesterhuis, W.J.; Barentsz, J.O.; Verdijk, P.; Krieken, J.H. van; Boerman, O.C.; Oyen, W.J.G.; Bonenkamp, J.J.; Boezeman, J.B.M.; Adema, G.J.; Bulte, J.W.M.; Scheenen, T.W.J.; Punt, C.J.A.; Heerschap, A.; Figdor, C.G. |
| 2005 | Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome | Vries, I.J.M. de; Bernsen, M.R.; Lesterhuis, W.J.; Scharenborg, N.M.; Strijk, S.P.; Gerritsen, M.J.P.; Ruiter, D.J.; Figdor, C.G.; Punt, C.J.A.; Adema, G.J. |
| 2005 | In vivo MR tracking of magnetically labeled cells: first clinical experience with dendritic cell vaccines in melanoma patients. | Vries, I.J.M. de; Lesterhuis, W.J.; Barentsz, J.O.; Verdijk, P.; Krieken, J.H.J.M. van; Boerman, O.C.; Oyen, W.J.G.; Bonenkamp, J.J.; Boezeman, J.B.M.; Adema, G.J.; Bulte, J.; Scheenen, T.W.J.; Punt, C.J.A.; Heerschap, A.; Figdor, C.G. |
| 2005 | Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. | Vries, I.J.M. de; Lesterhuis, W.J.; Barentsz, J.O.; Verdijk, P.; Krieken, J.H.J.M. van; Boerman, O.C.; Oyen, W.J.G.; Bonenkamp, J.J.; Boezeman, J.B.M.; Adema, G.J.; Bulte, J.W.; Scheenen, T.W.J.; Punt, C.J.A.; Heerschap, A.; Figdor, C.G. |
| 2005 | Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome. | Vries, I.J.M. de; Bernsen, M.R.; Lesterhuis, W.J.; Scharenborg, N.M.; Strijk, S.P.; Gerritsen, M.J.P.; Ruiter, D.J.; Figdor, C.G.; Punt, C.J.A.; Adema, G.J. |
| 2004 | Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results | Lesterhuis, W.J.; Vries, I.J.M. de; Adema, G.J.; Punt, C.J.A. |
| 2004 | Dendritic cell immunotherapy: mapping the way | Figdor, C.G.; Vries, I.J.M. de; Lesterhuis, W.J.; Melief, C.J.M. |
| 2004 | Acute generalised exanthematous pustulosis mimicking septic shock. | Lesterhuis, W.J.; Tjioe, M.; Stumpenhausen, G.A.; Crevel, R. van |
| 2004 | Dendritic cell immunotherapy: mapping the way. | Figdor, C.G.; Vries, I.J.M. de; Lesterhuis, W.J.; Melief, C.J. |
| 2003 | Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients | Vries, I.J.M. de; Lesterhuis, W.J.; Scharenborg, N.M.; Engelen, L.P.H.; Ruiter, D.J.; Gerritsen, M.J.P.; Croockewit, S.; Britten, C.M.; Torensma, R.; Adema, G.J.; Figdor, C.G.; Punt, C.J.A. |
| 2003 | Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state | Vries, I.J.M. de; Krooshoop, D.J.E.B.; Scharenborg, N.M.; Lesterhuis, W.J.; Diepstra, J.H.S.; Muijen, G.N.P. van; Strijk, S.P.; Ruers, T.J.M.; Boerman, O.C.; Oyen, W.J.G.; Adema, G.J.; Punt, C.J.A.; Figdor, C.G. |
| 2002 | Phenotypical and functional characterization of clinical grade dendritic cells | Vries, I.J.M. de; Eggert, A.A.O.; Scharenborg, N.M.; Vissers, J.L.M.; Lesterhuis, W.J.; Boerman, O.C.; Punt, C.J.A.; Adema, G.J.; Figdor, C.G. |
1
|